1199 Infliximab-Induced Psoriasis in Severe Pediatric Inflammatory Bowel Disease View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-11

AUTHORS

G Hiremath, L Duffy, I Leibowitz

ABSTRACT

Background: Inflammatory bowel disease (IBD) is the most significant chronic gastrointestinal disease affecting the pediatric population in western countries. Infliximab-a monoclonal anti-TNFantibody is frequently used in management of severe IBD, and other immune mediated inflammatory disorders including psoriasis. The paradox of infliximab-induced psoriasis (IIP) has been reported in adults, but has not been documented in pediatric IBD patients. More... »

PAGES

593

Journal

TITLE

Pediatric Research

ISSUE

S1

VOLUME

68

Identifiers

URI

http://scigraph.springernature.com/pub.10.1203/00006450-201011001-01199

DOI

http://dx.doi.org/10.1203/00006450-201011001-01199

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1019683751


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "familyName": "Hiremath", 
        "givenName": "G", 
        "id": "sg:person.01254523500.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254523500.53"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Duffy", 
        "givenName": "L", 
        "id": "sg:person.01256147377.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256147377.49"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Leibowitz", 
        "givenName": "I", 
        "id": "sg:person.01214251547.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214251547.33"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-11", 
    "datePublishedReg": "2010-11-01", 
    "description": "Background: Inflammatory bowel disease (IBD) is the most significant chronic gastrointestinal disease affecting the pediatric population in western countries. Infliximab-a monoclonal anti-TNFantibody is frequently used in management of severe IBD, and other immune mediated inflammatory disorders including psoriasis. The paradox of infliximab-induced psoriasis (IIP) has been reported in adults, but has not been documented in pediatric IBD patients.", 
    "genre": "non_research_article", 
    "id": "sg:pub.10.1203/00006450-201011001-01199", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1007352", 
        "issn": [
          "0031-3998", 
          "1530-0447"
        ], 
        "name": "Pediatric Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "S1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "1199 Infliximab-Induced Psoriasis in Severe Pediatric Inflammatory Bowel Disease", 
    "pagination": "593", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "5dc8cb03399fe4785479ee3143af81abe16bd8195c3b569240d6cbdc5300d8b8"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1203/00006450-201011001-01199"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1019683751"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1203/00006450-201011001-01199", 
      "https://app.dimensions.ai/details/publication/pub.1019683751"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000424.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/pr20101408"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1203/00006450-201011001-01199'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1203/00006450-201011001-01199'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1203/00006450-201011001-01199'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1203/00006450-201011001-01199'


 

This table displays all metadata directly associated to this object as RDF triples.

69 TRIPLES      20 PREDICATES      27 URIs      19 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1203/00006450-201011001-01199 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N8cd2d569b496436491c2470bcd4a9369
4 schema:datePublished 2010-11
5 schema:datePublishedReg 2010-11-01
6 schema:description Background: Inflammatory bowel disease (IBD) is the most significant chronic gastrointestinal disease affecting the pediatric population in western countries. Infliximab-a monoclonal anti-TNFantibody is frequently used in management of severe IBD, and other immune mediated inflammatory disorders including psoriasis. The paradox of infliximab-induced psoriasis (IIP) has been reported in adults, but has not been documented in pediatric IBD patients.
7 schema:genre non_research_article
8 schema:inLanguage en
9 schema:isAccessibleForFree true
10 schema:isPartOf N177586a5217b4bfe8c71480d99dcc0c8
11 Nd9058f0a92f9440993226154950482ae
12 sg:journal.1007352
13 schema:name 1199 Infliximab-Induced Psoriasis in Severe Pediatric Inflammatory Bowel Disease
14 schema:pagination 593
15 schema:productId N1c69b0e19c2d4e0e8ea1a482799afd1d
16 N45ef1a7b2b964eaf8eefb9f86c599a27
17 N6b97c963bd9d44ba837196778b7c2453
18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019683751
19 https://doi.org/10.1203/00006450-201011001-01199
20 schema:sdDatePublished 2019-04-11T00:03
21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
22 schema:sdPublisher N69708e69a1284bb8b065ae9aa11c4341
23 schema:url https://www.nature.com/articles/pr20101408
24 sgo:license sg:explorer/license/
25 sgo:sdDataset articles
26 rdf:type schema:ScholarlyArticle
27 N177586a5217b4bfe8c71480d99dcc0c8 schema:issueNumber S1
28 rdf:type schema:PublicationIssue
29 N1c69b0e19c2d4e0e8ea1a482799afd1d schema:name doi
30 schema:value 10.1203/00006450-201011001-01199
31 rdf:type schema:PropertyValue
32 N45ef1a7b2b964eaf8eefb9f86c599a27 schema:name dimensions_id
33 schema:value pub.1019683751
34 rdf:type schema:PropertyValue
35 N4630f4125f6f41a5a78098aa29f7a4c6 rdf:first sg:person.01214251547.33
36 rdf:rest rdf:nil
37 N5a59c4613bb44067930cc72078248961 rdf:first sg:person.01256147377.49
38 rdf:rest N4630f4125f6f41a5a78098aa29f7a4c6
39 N69708e69a1284bb8b065ae9aa11c4341 schema:name Springer Nature - SN SciGraph project
40 rdf:type schema:Organization
41 N6b97c963bd9d44ba837196778b7c2453 schema:name readcube_id
42 schema:value 5dc8cb03399fe4785479ee3143af81abe16bd8195c3b569240d6cbdc5300d8b8
43 rdf:type schema:PropertyValue
44 N8cd2d569b496436491c2470bcd4a9369 rdf:first sg:person.01254523500.53
45 rdf:rest N5a59c4613bb44067930cc72078248961
46 Nd9058f0a92f9440993226154950482ae schema:volumeNumber 68
47 rdf:type schema:PublicationVolume
48 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
49 schema:name Medical and Health Sciences
50 rdf:type schema:DefinedTerm
51 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
52 schema:name Immunology
53 rdf:type schema:DefinedTerm
54 sg:journal.1007352 schema:issn 0031-3998
55 1530-0447
56 schema:name Pediatric Research
57 rdf:type schema:Periodical
58 sg:person.01214251547.33 schema:familyName Leibowitz
59 schema:givenName I
60 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214251547.33
61 rdf:type schema:Person
62 sg:person.01254523500.53 schema:familyName Hiremath
63 schema:givenName G
64 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254523500.53
65 rdf:type schema:Person
66 sg:person.01256147377.49 schema:familyName Duffy
67 schema:givenName L
68 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01256147377.49
69 rdf:type schema:Person
 




Preview window. Press ESC to close (or click here)


...